Assessment of Safety, Tolerability and Drug Levels of NPM-119 in Participants With Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and drug levels of a
3-month exenatide implant (NPM-119) for the treatment of type 2 diabetes